Process Evaluation of a Double‐Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra‐Low‐Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA) is a research paper published in Journal of the American Heart Association (2023). On theSindex it has a DataRank of 0.278. It has been cited 5 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
9.24 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
NIDDK NIH HHS
Grant: P30 DK092949
NHLBI NIH HHS
Grant: R33 HL139852
NCATS NIH HHS
Grant: UL1 TR001422
NHLBI NIH HHS
Grant: K24 HL155897
National Institutes of Health
Grant: 7R33HL139852-04
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low dose treatment for hypertension (QUARTET USA)
National Institutes of Health
Grant: 5K24HL155897-04
Mentoring in community engaged implementation research to reduce cardiovascular disparities
National Institutes of Health
Grant: 5UL1TR001422-04
Northwestern University Clinical and Translational Science Institute (NUCATS)
FWCI
0.88
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals